Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-06

Clinical Trial Update: Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention [Phase 1]

View source ↗

Summary

This Phase 1 trial investigating intra-arterial neuroprotective agents with cold saline for ischemic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intra-Arterial Neuroprotective Agents and Cold Saline

Snippet

Sponsor: Northwell Health | Conditions: Stroke, Ischemic | Phase 1 | Status: WITHDRAWN